image-title

19

March

NCODA Announces Dr. Mario Lacouture as Director of the Medical Advisory Board for Treatment Support Program

FOR IMMEDIATE RELEASE

March 15, 2019

NCODA Announces Dr. Mario Lacouture as Director of the Medical Advisory Board for Treatment Support Program

Cazenovia, NY – The National Community Oncology Dispensing Association, Inc. (NCODA) Executive Council is pleased to announce that Mario Lacouture, M.D. will be joining the Treatment Support Program as Director of the Medical Advisory Board.

Dr. Lacouture is a board-certified dermatologist at Memorial Sloan Kettering Cancer Center in New York City, where he serves as Director of the Oncodermatology Program. Dr. Lacouture’s clinical career has focused on the recognition and management of side effects resulting from cancer treatments, affecting the skin, hair, and nails of cancer patients and survivors.

“It is a great day for NCODA!” proclaimed Michael Reff, Founder and Executive Director of NCODA, after learning that Mario Lacouture would be joining the Treatment Support Program team. Dr. Lacouture will start his work with the program in March. In his role as Director of the Medical Advisory Board, Dr. Lacouture will be providing expertise and guidance to the program committee.

The mission of NCODA’s Treatment Support Program is to provide patients and caregivers with resources that make sense for adherence and adverse effect management during treatment with anticancer medications. The priority is to equip healthcare professionals and patients with educational information and products that will be needed during the course of treatment. NCODA’s Treatment Support Kits are a fundamental component of the program.

TSK committee co-chairs Chris Kepinski, PharmD [Southern Oncology Specialists, NC] and Jamie Fritz, PharmD [Compass Oncology, WA] also see Dr. Lacouture as a great asset to the program. “Having an expert on the team who has seen first-hand how adverse effects of cancer treatments impact patient adherence is extremely important,” Kepinski said.

“The work that NCODA is doing with the Treatment Support Program is something that I fully support,” said Lacouture. “What better way to help patients than by providing them with the information and products they need to maintain their quality of life and health throughout their treatment course.”

For more information about NCODA’s Treatment Support Program visit: https://www.ncoda.org/treatment-support-kits.

See Full Press Release Here.

Victoria

Victoria has blogged 640 posts